Nls pharmaceutics invites patients, caregivers and other interested parties to attend international narcolepsy webinar

Zurich, switzerland / accesswire / january 12, 2022 / nls pharmaceutics ltd. (nasdaq:nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that wake up narcolepsy, a leading patient advocacy organization dedicated to serving the narcolepsy community, will host an online international narcolepsy webinar taking place on january 20-21, 2022.
NLSP Ratings Summary
NLSP Quant Ranking